Genesis Healthcare
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Cash used in financing activities reached the amount of $0 last year.
Cash Flow
| 2013 | 47.92M | -493K | -45.25M |
|---|---|---|---|
| 2014 | 26.32M | -11.82M | -15.04M |
| 2015 | 8.61M | -119.38M | 84.76M |
| 2016 | 68.36M | -12.78M | -65.70M |
| 2017 | 120.45M | 55.49M | -172.82M |
| 2018 | 18.58M | 11.87M | 53.17M |
| 2019 | -7.16M | -387.00M | 377.69M |
| 2020 | 315.73M | -33.53M | -94.78M |
| 2021 | 0 | 0 | 0 |
| 2022 | 0 | 0 | 0 |
GENN Cash Flow Statement (2013 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 0 | 262.06M | 125.80M | 142.27M | 58.63M | 51.40M | 61.54M | 87.54M | 4.17M | 2.00M |
Operating activities | ||||||||||
Net income | 0 | 0 | -103.36M | 7.47M | -372.41M | -959.20M | -118.05M | -526.76M | -907K | -10.48M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 0 | 0 | 107.83M | 123.15M | 220.89M | 255.78M | 254.45M | 237.76M | 24.23M | 24.62M |
Stock-based compensation expense | 0 | 0 | 6.48M | 7.30M | 0 | 9.62M | 8.41M | 28.47M | 4.26M | 2.99M |
| Deferred income tax benefit | 0 | 0 | 6.48M | 7.30M | 0 | 9.62M | 8.41M | 28.47M | 4.26M | 2.99M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 0 | 125.51M | 45.74M | 66.50M | -86.25M | -170.12M | -144.62M | -33.80M | -14.49M |
Inventories | 0 | 0 | -18.54M | 76.91M | 71.91M | -94.30M | -45.23M | 0 | 0 | -3.28M |
Accounts payable | 0 | 0 | 18.54M | -76.91M | -71.91M | 94.30M | 45.23M | 29.23M | 7.76M | 6.21M |
Cash generated by operating activities | 0 | 0 | 315.73M | -7.16M | 18.58M | 120.45M | 68.36M | 8.61M | 26.32M | 47.92M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | -79.28M | -70.31M | -79.65M | -48.59M | -52.55M | -83.91M | 0 | 0 |
Investments In Property Plant And Equipment | 0 | 0 | -55.61M | -62.72M | -51.15M | -64.10M | -93.11M | -85.72M | -12.98M | -13.43M |
Acquisitions Net | 0 | 0 | -17.52M | 62.72M | 51.15M | 142K | 5.92M | 25.96M | 30K | 0 |
Cash generated by investing activities | 0 | 0 | -33.53M | -387.00M | 11.87M | 55.49M | -12.78M | -119.38M | -11.82M | -493K |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 24K | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | -4.87B | 366.60M | -5.09B | -164.06M | -1.28B | 248.90M | -310.99M | -550.51M |
Cash used in financing activities | 0 | 0 | -94.78M | 377.69M | 53.17M | -172.82M | -65.70M | 84.76M | -15.04M | -45.25M |
Net Change In Cash | 0 | 0 | 187.41M | -16.47M | 83.63M | 3.11M | -10.13M | -26.00M | -548K | 2.17M |
Cash at end of period | 0 | 262.06M | 313.22M | 125.80M | 142.27M | 54.52M | 51.40M | 61.54M | 3.62M | 4.17M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |